Neo Auvra

Neo Auvra, founded in 2021, is a cutting-edge player in the Health Care, VR/AR, and Human Resources industries. Operating from its headquarters in Turkey, the company pioneers a VR-based assessment platform that marries neuroscience, cognitive sciences, and various health disciplines. Their technology facilitates cognitive, socio-emotional, physical, and metabolic evaluations, striving to fill a significant gap highlighted by the World Health Organization in 2022 regarding the absence of a global measure of brain health.

With a focus on improving brain function and overall health via biometric precision, Neo Auvra stands out for its clinically validated approach. The platform's comprehensive diagnostic capabilities cater to an increasing demand for advanced healthcare technologies. As of May 2023, the company secured a $500.00K Seed investment, demonstrating both potential and early-stage attractiveness to investors. This financial backing reinforces the company’s capacity to innovate within the health-tech landscape.